The "Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032" report has been added to ...

Medical researchers in Japan have discovered a way to predict a potentially life-threatening side effect of cancer immunotherapy before it occurs.

In a study published in Scie nce Advances, Mayo Clinic researchers found a new immunotherapy target called a cryptic antigen that may be key in helping the immune system fight tumors in ovarian cancer ...

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune system fight tumors in ovarian cancer. The study, published in Science ...

Medically reviewed by Daniel More, MD Medications that target inflammation, such as immunotherapy and steroids, treat ...

New findings could help make immunotherapies for brain cancer more effective. The team analyzed almost 200,000 individual immune cells in tumor samples taken from patients with glioma, the most common ...

Researchers have discovered a new approach to prostate cancer treatment by combining immunotherapy with PIM1 kinase ...

By convention, antibody drugs (immunotherapy) target extracellular oncoproteins, while small chemical compounds (chemotherapy) target intracellular oncoproteins, such as PRL3 intracellular ...

Versamune ® is a registered trademark of PDS Biotechnology Corporation. Investor Contact: Mike Moyer LifeSci Advisors Phone +1 (617) 308-4306 Email: mmoyer@lifesciadvisors.com ...

In the third episode of a six-part interview series on immunotherapy, Marc Voigt, CEO and Executive Director of Immutep ...